Advisory Alpha, LLC Novo Nordisk A S Transaction History

Advisory Alpha, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$49.86 - $58.26 $1,196 - $1,398	-24 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$47.54 - $53.43 $1,140 - $1,282	24 New	24 $1,000
Q2 2019 Aug 16, 2019	SELL	$46.79 - $52.47 $1,122 - $1,259	-24 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$46.36 - $52.63 $1,112 - $1,263	24 New	24 $0

1,955

318M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $193B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Advisory Alpha, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Alpha, LLC with notifications on news.